US FDA Seeks Input On Cosmetics GMP Development, Industry Costs, Likely Safety Impacts

The agency is accepting comments from 27 April to 3 July 2023 to Docket No. FDA-2023-N-1466 to inform its development of good manufacturing practices for facilities that manufacture or process cosmetic products distributed in the United States. A virtual “listening session” is slated for 1 June.

Stakeholders will have a first opportunity to inform the US Food and Drug Administration’s development of good manufacturing practices for the cosmetics industry at a 1 June virtual “listening session.”

The agency provided additional detail on 26 April after announcing the public meeting two weeks earlier, outlining key topics of...